|   Saracatinib difumarate structure | Common Name | Saracatinib difumarate | ||
|---|---|---|---|---|
| CAS Number | 893428-72-3 | Molecular Weight | 774.171 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C35H40ClN5O13 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Use of Saracatinib difumarateSaracatinib (AZD0530) difumarate is a potent Src inhibitor with IC50 values of 2.7-11 nM for c-Src, Lck, c-YES, Lyn, Fyn, Fgr and Blk, and is selective for other tyrosine kinases. [1]. | 
| Name | (E)-but-2-enedioic acid,N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine | 
|---|---|
| Synonym | More Synonyms | 
| Description | Saracatinib (AZD0530) difumarate is a potent Src inhibitor with IC50 values of 2.7-11 nM for c-Src, Lck, c-YES, Lyn, Fyn, Fgr and Blk, and is selective for other tyrosine kinases. [1]. | 
|---|---|
| Related Catalog | |
| Target | IC50: 2.7 nM (Src), 30 nM (v-Abl), 66 nM (EGFR), 200 nM (c-Kit)[1] | 
| References | 
| Molecular Formula | C35H40ClN5O13 | 
|---|---|
| Molecular Weight | 774.171 | 
| Exact Mass | 773.231140 | 
| PSA | 239.64000 | 
| LogP | 3.31190 | 
| Saracatinib difumarate | 
| N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)-4-quinazolinamine (2E)-2-butenedioate (1:2) | 
| UNII-8R1DYT4EAW | 
| AZD-0530 difumarate | 
| 4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2) |